Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Evaluation of Cancer Signal Origin Prediction and Diagnostic Resolution following Multicancer Early Detection Testing in the PATHFINDER Study.

Cancer prevention research (Philadelphia, Pa.)·2025
Same author

Navigating Complexity: Perspectives on Risk Assessment in the Era of New Blood-Based Tests for Early Cancer Detection.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Testosterone Replacement Therapy and Risk of COVID-19 and Effect of COVID-19 on Testosterone's Treatment Effect.

Journal of the Endocrine Society·2025
Same author

CpgD is a phosphoglycerate cytidylyltransferase required for ceramide diphosphoglycerate synthesis.

bioRxiv : the preprint server for biology·2025
Same author

A histidine-rich extension of the mitochondrial F<sub>0</sub> subunit ATP6 from the ice worm Mesenchytraeus solifugus increases ATP synthase activity in bacteria.

FEBS letters·2025
Same author

Low Baseline IsoPSA Index is Associated With a Prolonged Low Risk of Clinically Significant Prostate Cancer Diagnosis in Men With an Elevated PSA.

Urology·2025

Related Experiment Video

Updated: May 21, 2026

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

High-grade prostatic intraepithelial neoplasia.

Joseph C Klink1, Ranko Miocinovic, Cristina Magi Galluzzi

  • 1Glickman Urologic and Kidney Institute, Cleveland, Ohio, USA.

Korean Journal of Urology
|June 7, 2012
PubMed
Summary

High-grade prostatic intraepithelial neoplasia (HGPIN) is a precursor to prostate cancer. Repeat biopsies are recommended for large-volume HGPIN to monitor progression.

Keywords:
HGPINHigh grade prostatic intraepithelial neoplasiaProstate biopsyProstate cancer

More Related Videos

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

Related Experiment Videos

Last Updated: May 21, 2026

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

Area of Science:

  • Urology
  • Oncology
  • Pathology

Background:

  • High-grade prostatic intraepithelial neoplasia (HGPIN) is a recognized precursor to prostatic adenocarcinoma.
  • HGPIN shares significant morphological, genetic, and molecular similarities with prostate cancer.
  • The predictive value of HGPIN for subsequent adenocarcinoma has diminished due to increased prostate biopsy cores.

Purpose of the Study:

  • To review the current understanding of HGPIN as a precursor lesion.
  • To evaluate the implications of HGPIN findings in contemporary prostate cancer screening.
  • To provide guidance on the management of HGPIN.

Main Methods:

  • Literature review of studies on HGPIN and prostate cancer.
  • Analysis of the impact of increased prostate biopsy sampling on HGPIN detection.
  • Synthesis of evidence regarding the clinical significance of HGPIN.

Main Results:

  • HGPIN remains a significant indicator of future prostate cancer risk.
  • Large-volume HGPIN and multifocal involvement warrant close monitoring.
  • Current evidence suggests repeat prostate biopsy within one year for specific HGPIN findings.

Conclusions:

  • HGPIN is a critical precursor lesion requiring vigilant follow-up.
  • Management strategies should adapt to increased biopsy sampling.
  • No specific treatment is currently recommended for HGPIN to prevent cancer progression, emphasizing surveillance.